NSE
Nephrocare Health Services LimitedNEPHROPLUS
Nephrocare Health Services Limited is an NSE-listed company (NEPHROPLUS).
AI-generated overview — verify before relying on it.
Net institutional flow
+₹172 Cr
Institutional buyers
3 in / 1 out
High-impact filings
0 · tilt Neutral
Next corporate action
—
| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | ATALREAL | +₹12.8 Cr | 131 | — | — | — | — |
| 2 | NEPHROPLUSThis | — | — | — | — | — | — |
| 3 | MOBIKWIK | +₹0 Cr | 60 | — | — | — | — |
| 4 | QUADFUTURE | +₹0 Cr | 34 | — | — | — | — |
| 5 | MTNL | — | — | — | — | — | — |
| 6 | GATECH | +₹0 Cr | 6 | — | — | — | — |
| 7 | IRMENERGY | −₹2.2 Cr | 328 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
- 2026-06-17FilingHealthcare Parent Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the SecShareholding Disclosure
- 2026-06-12Filing Vikram Vuppala has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities aShareholding Disclosure
- 2026-06-11FilingNephrocare Health Services Limited has informed the Exchange about Schedule of meetInvestor Call
- 2026-06-10Filing Bessemer Venture Partners Trust has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) ofShareholding Disclosure
- 2026-06-10FilingNephrocare Health Services Limited has informed the Exchange about AgreementsAgreements
Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
- 2Shareholding DisclosureNeutral
a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Source PDF → - 2Shareholding DisclosureNeutral
a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Source PDF → - 2
- 2Shareholding DisclosureNeutral
a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Source PDF → - 2
No bulk/block deals for NEPHROPLUS in this window.
Results & transcripts
Financial results
None yet.
News & chatter on NEPHROPLUS
RSS News
0No recent news.
Google News RSS — links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.